Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

References

• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835–2838. doi:10.1001/jama.1986.033802000730243773200
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15. doi:10.1161/01.CIR.79.1.82642759
   PubMed Web of Science ®Google Scholar
• Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992;2(1–2):23–28. doi:10.1016/1047-2797(92)90033-M1342260
   PubMedGoogle Scholar
• Hague WE, Simes J, Kirby A, et al. Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: sixteen years of follow-up of the LIPID Study. Circulation. 2016;133(19):1851–1860. doi:10.1161/CIRCULATIONAHA.115.01858027016105
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25Pt B):2889–2934. doi:10.1016/j.jacc.2013.11.00224239923
   PubMed Web of Science ®Google Scholar
• Postmus I, Verschuren JJ, de Craen AJ, et al. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives. Pharmacogenomics. 2012;13(7):831–840. doi:10.2217/pgs.12.2522594514
   PubMed Web of Science ®Google Scholar
• Chasman DI, Posada D, Subrahmanyan L, et al. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA. 2004;291(23):2821–2827. doi:10.1001/jama.291.23.282115199031
   PubMed Web of Science ®Google Scholar
• Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996;271(5248):518–520. doi:10.1126/science.271.5248.5188560269
   PubMed Web of Science ®Google Scholar
• Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA. 1997;94(23):12610–12615. doi:10.1073/pnas.94.23.126109356497
   PubMed Web of Science ®Google Scholar
• West M, Greason E, Kolmakova A, et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab. 2009;94(4):1451–1457. doi:10.1210/jc.2008-122319158204
   PubMed Web of Science ®Google Scholar
• Acton S, Osgood D, Donoghue M, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol. 1999;19(7):1734–1743. doi:10.1161/01.ATV.19.7.173410397692
   PubMed Web of Science ®Google Scholar
• Morabia A, Ross BM, Costanza MC, et al. Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis. 2004;175(1):159–168. doi:10.1016/j.atherosclerosis.2004.03.01415186961
   PubMed Web of Science ®Google Scholar
• Cerda Á, Genvigir FDV, Arazi SS, et al. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clin Chim Acta. 2010;411(9–10):631–637. doi:10.1016/j.cca.2010.01.00220064494
   PubMed Web of Science ®Google Scholar
• Wu DF, Yin RX, Hu XJ, et al. Association of rs5888 SNP in the scavenger receptor class B type 1 gene and serum lipid levels. Lipids Health Dis. 2012;11:50. doi:10.1186/1476-511X-11-5022583964
   PubMed Web of Science ®Google Scholar
• Wu DF, Yin RX, Cao XL, et al. Scavenger receptor class B type 1 gene rs5888 single nucleotide polymorphism and the risk of coronary artery disease and ischemic stroke: a case-control study. Int J Med Sci. 2013;10(12):1771–1777. doi:10.7150/ijms.704424151447
   PubMed Web of Science ®Google Scholar
• Xhyheri B, Bugiardini R. Diagnosis and treatment of heart disease: are women different from men? Prog Cardiovasc Dis. 2010;53(3):227–236. doi:10.1016/j.pcad.2010.07.00421130920
   PubMed Web of Science ®Google Scholar
• Wu DF, Wu YX, Deng JL. Changes in homocysteine levels affect serum lipid response to atorvastatin in patients with acute coronary syndrome: a Retrospective Observational Study. Clin Appl Thromb Hemost. 2020;26:1076029620920369. doi:10.1177/107602962092036932392083
   PubMed Web of Science ®Google Scholar
• Zhao P, Liu S, Zhong Z, Liu J. Age- and sex-related difference of lipid profile in patients with ischemic stroke in China. Medicine. 2018;97(23):e10930. doi:10.1097/MD.000000000001093029879034
   PubMed Web of Science ®Google Scholar
• Wei Y, Qi B, Xu J, et al. Age- and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China. J Clin Lipidol. 2014;8(6):562–567. doi:10.1016/j.jacl.2014.09.00625499938
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801–1811.10362825
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603.28122885
   PubMed Web of Science ®Google Scholar
• Taqueti VR. Sex differences in the coronary system. Adv Exp Med Biol. 2018;1065:257–278.30051390
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Badimon L, Corti R, et al. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res. 2011;90(1):9–17. doi:10.1093/cvr/cvq39421159671
   PubMed Web of Science ®Google Scholar
• Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem. 1988;34(8B):B60–B70.3042201
   PubMed Web of Science ®Google Scholar
• Faubion SS, Kapoor E, Moyer AM, Hodis HN, Miller VM. Statin therapy: does sex matter? Menopause. 2019;26(12):1425–1435. doi:10.1097/GME.000000000000141231513091
   PubMed Web of Science ®Google Scholar
• Mombelli G, Bosisio R, Calabresi L, et al. Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention. J Clin Lipidol. 2015;9(2):226–233. doi:10.1016/j.jacl.2014.12.00325911079
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhao L, Liang L, Xie G, Wu Y. Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy. Lipids Health Dis. 2012;11:59. doi:10.1186/1476-511X-11-5922642757
   PubMed Web of Science ®Google Scholar
• Ansell BJ, Fonarow GC, Maki KC, et al. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am Heart J. 2006;152(5):976–981. doi:10.1016/j.ahj.2006.05.01317070174
   PubMed Web of Science ®Google Scholar
• Roberts CGP, Shen H, Mitchell BD, et al. Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women. Hum Hered. 2007;64(2):107–113. doi:10.1159/00010196217476110
   PubMed Web of Science ®Google Scholar
• Osgood D, Corella D, Demissie S, et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J Clin Endocrinol Metab. 2003;88(6):2869–2879. doi:10.1210/jc.2002-02166412788901
   PubMed Web of Science ®Google Scholar
• Hong SH, Kim Y-R, Yoon YM, et al. Association between HaeIII polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration. Ann Clin Biochem. 2002;39(5):478–481. doi:10.1258/00045630232031448512227853
   PubMed Web of Science ®Google Scholar
• Rejeb J, Omezzine A, Boumaiza I, et al. Association of three polymorphisms of scavenger receptor class BI gene (exon8, exon1, intron5) with coronary stenosis in a coronary Tunisian population. Gene. 2012;511(2):383–388. doi:10.1016/j.gene.2012.09.07023041084
   PubMed Web of Science ®Google Scholar
• Stanislovaitiene D, Lesauskaite V, Zaliuniene D, et al. SCARB1 single nucleotide polymorphism (rs5888) is associated with serum lipid profile and myocardial infarction in an age- and gender-dependent manner. Lipids Health Dis. 2013;12(1):24. doi:10.1186/1476-511X-12-2423510561
   PubMed Web of Science ®Google Scholar
• Yoon M. PPAR α in obesity: sex difference and estrogen involvement. PPAR Res. 2010;2010:584296. doi:10.1155/2010/58429620871824
   PubMed Web of Science ®Google Scholar
• Smiderle L, Fiegenbaum M, Hutz MH, et al. ESR1 polymorphisms and statin therapy: a sex-specific approach. Pharmacogenomics J. 2016;16(6):507–513. doi:10.1038/tpj.2015.6026302681
   PubMed Web of Science ®Google Scholar
• Chiba-Falek O, Nichols M, Suchindran S, et al. Impact of gene variants on sex-specific regulation of human scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study. BMC Med Genet. 2010;11:9. doi:10.1186/1471-2350-11-920085651
   PubMed Web of Science ®Google Scholar